| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.92B | 103.76B | 101.01B | 92.33B | 94.51B | 76.09B |
| Gross Profit | 22.40B | 22.36B | 21.26B | 17.37B | 18.76B | 17.67B |
| EBITDA | 5.22B | 6.29B | 4.91B | 2.63B | 4.18B | 5.43B |
| Net Income | 791.00M | 2.35B | 763.00M | -1.16B | 885.73M | 1.75B |
Balance Sheet | ||||||
| Total Assets | 101.00B | 102.89B | 100.04B | 98.58B | 92.44B | 78.91B |
| Cash, Cash Equivalents and Short-Term Investments | 4.93B | 6.26B | 4.75B | 6.85B | 6.30B | 6.63B |
| Total Debt | 42.03B | 40.42B | 42.56B | 39.37B | 33.67B | 21.50B |
| Total Liabilities | 64.06B | 61.38B | 62.03B | 57.70B | 51.62B | 38.80B |
| Stockholders Equity | 36.27B | 40.80B | 37.33B | 37.22B | 37.10B | 36.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.28B | 684.00M | -2.94B | -3.99B | 243.85M |
| Operating Cash Flow | 0.00 | 7.86B | 6.14B | 353.00M | -466.24M | 2.83B |
| Investing Cash Flow | 0.00 | -1.71B | -4.98B | -3.20B | -6.65B | -3.44B |
| Financing Cash Flow | 0.00 | -4.85B | -3.67B | 2.90B | 7.66B | 2.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥29.82B | 14.81 | ― | 3.63% | 43.31% | 13.90% | |
71 Outperform | ¥34.37B | 5.80 | ― | 3.84% | 3.45% | 14.22% | |
67 Neutral | ¥28.94B | 39.81 | ― | 3.21% | 2.43% | 17.77% | |
65 Neutral | ¥28.27B | 17.68 | ― | 2.47% | 2.49% | 2.71% | |
64 Neutral | ¥27.20B | 11.36 | ― | 4.27% | 2.37% | -16.75% | |
62 Neutral | ¥24.16B | 9.42 | ― | 4.62% | 2.73% | 206.70% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |